Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Total Current Liabilities: 2017-2018

Historic Total Current Liabilities for Astria Therapeutics (ATXS) over the last 2 years, with Dec 2018 value amounting to $4.2 million.

  • Astria Therapeutics' Total Current Liabilities rose 34.81% to $5.6 million in Q3 2019 from the same period last year, while for Sep 2019 it was $5.6 million, marking a year-over-year increase of 34.81%. This contributed to the annual value of $4.2 million for FY2018, which is 30.67% down from last year.
  • According to the latest figures from FY2018, Astria Therapeutics' Total Current Liabilities is $4.2 million, which was down 30.67% from $6.0 million recorded in FY2017.
  • Over the past 5 years, Astria Therapeutics' Total Current Liabilities peaked at $6.0 million during FY2017, and registered a low of $4.2 million during FY2018.
  • Over the past 2 years, Astria Therapeutics' median Total Current Liabilities value was $5.1 million (recorded in 2017), while the average stood at $5.1 million.
  • Data for Astria Therapeutics' Total Current Liabilities shows a maximum YoY tumbled of 30.67% (in 2018) over the last 5 years.
  • Over the past 2 years, Astria Therapeutics' Total Current Liabilities (Yearly) stood at $6.0 million in 2017, then crashed by 30.67% to $4.2 million in 2018.